nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00206	0.00206	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.00205	0.00205	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.00205	0.00205	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.00203	0.00203	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IFNA1—pancreatic cancer	0.00203	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.00199	0.00199	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00198	0.00198	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SCT—pancreatic cancer	0.00197	0.00197	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PRSS1—pancreatic cancer	0.00192	0.00192	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—SHH—pancreatic cancer	0.0019	0.0019	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IFNA2—pancreatic cancer	0.00189	0.00189	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GAST—pancreatic cancer	0.00189	0.00189	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCK—pancreatic cancer	0.00188	0.00188	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IAPP—pancreatic cancer	0.00187	0.00187	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SSTR3—pancreatic cancer	0.00185	0.00185	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DTX1—pancreatic cancer	0.00185	0.00185	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CNR2—pancreatic cancer	0.00183	0.00183	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00183	0.00183	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—SST—pancreatic cancer	0.00181	0.00181	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCKAR—pancreatic cancer	0.0018	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PTHLH—pancreatic cancer	0.0018	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PTCH1—pancreatic cancer	0.0018	0.0018	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SCT—pancreatic cancer	0.00179	0.00179	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SSTR1—pancreatic cancer	0.00177	0.00177	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.00177	0.00177	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PPY—pancreatic cancer	0.00174	0.00174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRLHR—pancreatic cancer	0.00171	0.00171	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SSTR2—pancreatic cancer	0.00171	0.00171	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCK—pancreatic cancer	0.00171	0.00171	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.00167	0.00167	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ARG2—pancreatic cancer	0.00167	0.00167	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CNR2—pancreatic cancer	0.00166	0.00166	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GLP1R—pancreatic cancer	0.00166	0.00166	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCKBR—pancreatic cancer	0.00165	0.00165	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—SST—pancreatic cancer	0.00165	0.00165	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00164	0.00164	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCKAR—pancreatic cancer	0.00164	0.00164	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IAPP—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GCG—pancreatic cancer	0.00162	0.00162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ACVR1B—pancreatic cancer	0.00161	0.00161	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ZNRF3—pancreatic cancer	0.00161	0.00161	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00156	0.00156	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DTX4—pancreatic cancer	0.00155	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GLI1—pancreatic cancer	0.00155	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.00154	0.00154	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.00152	0.00152	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRP1—pancreatic cancer	0.00151	0.00151	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00151	0.00151	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SHH—pancreatic cancer	0.00149	0.00149	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IAPP—pancreatic cancer	0.00147	0.00147	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GCG—pancreatic cancer	0.00147	0.00147	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TYMP—pancreatic cancer	0.00146	0.00146	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR3—pancreatic cancer	0.00145	0.00145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DTX1—pancreatic cancer	0.00145	0.00145	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HEY2—pancreatic cancer	0.00145	0.00145	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SST—pancreatic cancer	0.00142	0.00142	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.00142	0.00142	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAST—pancreatic cancer	0.00142	0.00142	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PTCH1—pancreatic cancer	0.00141	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PTHLH—pancreatic cancer	0.00141	0.00141	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.0014	0.0014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR1—pancreatic cancer	0.00139	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.00138	0.00138	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PPY—pancreatic cancer	0.00137	0.00137	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SCT—pancreatic cancer	0.00134	0.00134	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HEY1—pancreatic cancer	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR2—pancreatic cancer	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PLAU—pancreatic cancer	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CNR1—pancreatic cancer	0.00131	0.00131	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCKBR—pancreatic cancer	0.0013	0.0013	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SST—pancreatic cancer	0.00129	0.00129	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00129	0.00129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCK—pancreatic cancer	0.00128	0.00128	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.00127	0.00127	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GCG—pancreatic cancer	0.00127	0.00127	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	0.00125	0.00125	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.00125	0.00125	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.00125	0.00125	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.00123	0.00123	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DTX4—pancreatic cancer	0.00122	0.00122	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GLI1—pancreatic cancer	0.00122	0.00122	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.00121	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CNR1—pancreatic cancer	0.00119	0.00119	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CG—pancreatic cancer	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRP1—pancreatic cancer	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—EGF—pancreatic cancer	0.00118	0.00118	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	0.00118	0.00118	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GLP1R—pancreatic cancer	0.00118	0.00118	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—DPYD—pancreatic cancer	0.00116	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GCG—pancreatic cancer	0.00115	0.00115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HEY2—pancreatic cancer	0.00114	0.00114	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SHH—pancreatic cancer	0.00112	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAST—pancreatic cancer	0.00111	0.00111	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.00111	0.00111	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	0.00111	0.00111	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGTR1—pancreatic cancer	0.0011	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SLC2A2—pancreatic cancer	0.0011	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.00108	0.00108	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.00106	0.00106	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.00106	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SCT—pancreatic cancer	0.00106	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HEY1—pancreatic cancer	0.00106	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CD—pancreatic cancer	0.00105	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCK—pancreatic cancer	0.00101	0.00101	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CNR2—pancreatic cancer	0.000983	0.000983	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GLP1R—pancreatic cancer	0.000983	0.000983	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000982	0.000982	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SST—pancreatic cancer	0.000972	0.000972	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCKAR—pancreatic cancer	0.000967	0.000967	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000959	0.000959	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000951	0.000951	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000947	0.000947	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAG2—pancreatic cancer	0.000937	0.000937	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	0.000924	0.000924	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	0.000914	0.000914	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000897	0.000897	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000883	0.000883	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	0.000881	0.000881	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000876	0.000876	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000871	0.000871	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	0.00087	0.00087	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GCG—pancreatic cancer	0.000867	0.000867	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CD44—pancreatic cancer	0.00085	0.00085	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000843	0.000843	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	0.000836	0.000836	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	0.000836	0.000836	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000827	0.000827	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STK11—pancreatic cancer	0.000815	0.000815	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GCG—pancreatic cancer	0.000815	0.000815	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—STK11—pancreatic cancer	0.000766	0.000766	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000766	0.000766	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SST—pancreatic cancer	0.000764	0.000764	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000754	0.000754	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	0.000748	0.000748	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000745	0.000745	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000735	0.000735	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SRC—pancreatic cancer	0.000732	0.000732	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000714	0.000714	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	0.000713	0.000713	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000706	0.000706	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	0.000705	0.000705	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NRAS—pancreatic cancer	0.000704	0.000704	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HES1—pancreatic cancer	0.000697	0.000697	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000684	0.000684	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	0.000681	0.000681	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000667	0.000667	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000663	0.000663	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TYMS—pancreatic cancer	0.000659	0.000659	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	0.000655	0.000655	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	0.00065	0.00065	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000641	0.000641	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	0.00064	0.00064	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TERT—pancreatic cancer	0.000611	0.000611	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—KRAS—pancreatic cancer	0.000606	0.000606	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000602	0.000602	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000584	0.000584	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	0.000582	0.000582	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000578	0.000578	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOE—pancreatic cancer	0.00057	0.00057	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	0.000561	0.000561	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KDR—pancreatic cancer	0.000558	0.000558	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	0.000557	0.000557	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000555	0.000555	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	0.000548	0.000548	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TP53—pancreatic cancer	0.000539	0.000539	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOE—pancreatic cancer	0.000536	0.000536	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000531	0.000531	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000526	0.000526	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000524	0.000524	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	0.000515	0.000515	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000514	0.000514	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	0.000514	0.000514	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGF—pancreatic cancer	0.000508	0.000508	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000504	0.000504	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	0.000484	0.000484	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	0.00048	0.00048	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	0.000469	0.000469	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARG—pancreatic cancer	0.000467	0.000467	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	0.000459	0.000459	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	0.000458	0.000458	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	0.000455	0.000455	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000452	0.000452	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	0.000448	0.000448	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000448	0.000448	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	0.000443	0.000443	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	0.000439	0.000439	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	0.000425	0.000425	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000417	0.000417	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000413	0.000413	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000407	0.000407	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000404	0.000404	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	0.000404	0.000404	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	0.0004	0.0004	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000394	0.000394	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	0.000379	0.000379	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	0.000376	0.000376	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	0.000371	0.000371	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	0.000368	0.000368	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	0.000367	0.000367	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000366	0.000366	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	0.000363	0.000363	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000355	0.000355	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	0.000353	0.000353	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000352	0.000352	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000349	0.000349	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	0.000348	0.000348	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	0.000343	0.000343	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	0.000341	0.000341	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	0.000332	0.000332	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTEN—pancreatic cancer	0.00032	0.00032	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.00032	0.00032	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	0.000316	0.000316	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	0.00031	0.00031	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	0.000308	0.000308	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	0.000305	0.000305	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	0.000304	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	0.000298	0.000298	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	0.000296	0.000296	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000288	0.000288	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	0.000285	0.000285	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	0.000283	0.000283	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	0.000282	0.000282	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	0.000277	0.000277	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	0.000277	0.000277	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000275	0.000275	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	0.000269	0.000269	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	0.000268	0.000268	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	0.000262	0.000262	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	0.000261	0.000261	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	0.000248	0.000248	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	0.000242	0.000242	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	0.00024	0.00024	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	0.000239	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	0.000239	0.000239	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	0.000232	0.000232	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	0.000226	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	0.000222	0.000222	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	0.000222	0.000222	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	0.000222	0.000222	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	0.000218	0.000218	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	0.000206	0.000206	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	0.000196	0.000196	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	0.000189	0.000189	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—pancreatic cancer	0.000185	0.000185	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	0.000183	0.000183	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	0.000175	0.000175	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	0.000154	0.000154	CbGpPWpGaD
